Bolivia's Morales, in Greece, backs Venezuela's Maduro
Mar 14, 2019
Bolivia's left-wing president has compared Venezuelan opposition leader Juan Guaido to an erstwhile colonial viceroy and spoke out against any military intervention in the troubled country
ATHENS, Greece — Bolivia's left-wing president on Thursday compared Venezuelan opposition leader Juan Guaido to an erstwhile colonial viceroy and spoke out against any military intervention in the troubled country.
"Are we returning to colonial times?" Evo Morales said in a speech in Athens, during a rare trip to Europe. "Like Juan Guaido ... has he been recognized as the viceroy of Latin America? I don't understand that."
"Any armed intervention won't solve social, or political, problems," Morales said of Venezuela, which has been battered by hyperinflation and widespread shortages of food and medicine. "I salute the resistance of the Venezuelan people, despite the economic blockade, the energy blackouts, the threats of intervention."
His talks with Greece's left-wing Prime Minister Alexis Tsipras on Friday are expected to include the political and economic crisis in Venezuela.
Guaido, the leader of Venezuela's opposition-controlled congress, is seeking to oust socialist President Nicolas Maduro, with whom Morales has maintained his alliance throughout the crisis.
Tsipras' Syriza party has friendly ties with left-wing parties in South America. In late January, the party expressed "full support and solidarity" with Maduro, in contrast with the major European Union members that along with the U.S. are among 50 nations that have expressed support for Guaido.
Morales arrived in Greece on Thursday for a two-day visit after travelling from Austria, where he attended a United Nations conference on combatting drug trafficking and abuse globally.
More News
Trump Offers Putin Economic Relief in Hopes That Russia Will Return the Favor
The Trump administration is ignoring the will of Congress and waiving new Russia sanctions amid fears that high energy prices will cost Republicans in next month’s elections.
How day of protests unfolded as disorder breaks out across France
Demonstrations across the country turned violent, with cars and buildings set alight and shops ransacked.
M.L.B. Playoff Ads With Sydney Sweeney and Megan Fox Draw Backlash
Commercials promoting a gambling platform and endorsing male enhancement have rankled fans, and even athletes. Who is in charge?
Weak Links Start to Show in A.I. Borrowing
Debt trouble at CoreWeave, Oracle and SoftBank raises questions about whether there are broader problems with the data center build-out.
The Reporter Who Exposed Elizabeth Holmes on Nathan Fielder’s Documentary
Ms. Holmes handed the makers of “You Can See Everything” — and the rest of the world — a microscope with which to observe and dissect her lies.
Can Cereal Be Healthy? Big Companies Are Trying.
As more Americans turn away from the snap, crackle and sugar, the industry is trying to capitalize on our current obsession with wellness.
Low-cost clinic helps pet owners with vet bills
RSPCA Medway West launches its clinic for the pets of people with low incomes.
States Are Stepping Up as the New Antitrust Enforcers
With the Trump administration taking a relaxed approach, attorneys general around the country have ramped up their scrutiny of mergers.
Corporate Tax Revenue Falls Even as Profits Soar Under Trump
The annual decline was about $70 billion. Companies are writing off billions in A.I. investments, taking advantage of tax cuts that President Trump signed into law.
It’s Time to Shop Medicare, and This Year, It’s Extra Important
Be sure to read your mail this fall — big changes to prescription drug plans and Medicare Advantage provider networks are coming, and could cost you more.
Weak Links Start to Show in A.I. Borrowing
Debt trouble at CoreWeave, Oracle and SoftBank raises questions about whether there is broader trouble with the data center build-out.
Call for more food funding due to high living cost
Deputy Louise Doublet does not think the cost of living was considered in the ending of a trial.